Sympathoadrenal system (SAS) represents a major contributor to body homeostasis, regulating blood pressure heart rate, energy balance and intermediary metabolism. Thus, it is not unexpected that in last decades a consistent literature has been focused on the possible role of sympathoadrenal system in the pathogenesis of human obesity. There are, however, many factors confounding comparison of sympathoadrenal system activity between lean and obese subjects. Among these, one should be aware that SAS should be functionally separated into sympathetic nervous system (SNS) and adrenal medulla (AM), and that each of these two systems can be activated independently from the other by distinct physiological stimuli; this phenomenon in fact underlies the discordant pattern of ®ndings for adrenomedullary and sympathetic activity in human obesity. While, in fact, obese subjects often display an increased basal SNS activity, there are numerous reports of blunted AM function in obese. Recent evidence suggests that this reduced adrenaline secretion is an acquired feature of human obesity, a ®nding that ®ts in well with the hypothesis that hormonal mileu, particularly sex steroids and cortisol, plays a role in the determination of blunted AM activity. Catecholamines have been recently demonstrated to play a role also in the regulation of whole energy balance. Adrenaline in fact acutely reduces both leptin mRNA as well as circulating leptin in human obese subjects, suggesting that catecholamines may in¯uence the cross-talk between energy stores and the centrally mediated modulation of food intake. In summary, the study of adrenomedullary function and of possible mechanisms of its disturbances in human obesity, appears of great interest, and surely deserves further investigations.
Introduction
The sympathoadrenal system represents a major contributor to body homeostasis, regulating blood pressure, heart rate and energy metabolism and ensuring the maintenance of constant body temperature. 1 Catecholamines also play a major role in the regulation of intermediary metabolism, affecting glucose production and utilization, fat mobilization and protein metabolism. These effects are mediated both through stimulation of speci®c adrenoceptors in metabolically active tissues and through interactions with other endocrine functions, such as insulin and glucagon secretion, which in turn modify peripheral tissues sensitivity to catecholamines. 1 It is well known that the sympathoadrenal system is a major determinant of energy balance.
Catecholamines increase oxygen consumption in muscle, independently rising muscle electromyogram (non-shivering thermogenesis), and in splanchnic organs. 2 The role of the sympathoadrenal system in humans is emphasized when considering adaptive responses occurring at birth. 3 Consistent evidence exists for the importance of adrenomedullary secretion in circulatory adjustments which follow delivery. Studies comparing infants delivered vaginally or via caesarean section support the role of stress-induced catecholamine secretion in pulmonary adaptation and surfactant production. Plasma levels of glucose and free fatty acids increase immediately after delivery and it has been shown that this phenomenon is strictly related to a prompt postnatal elevation of circulating adrenaline. 3 Several studies based on intravenous infusion of adrenaline in healthy individuals 4 have shown that venous plasma levels above 0.5 nmolal affect heart rate, blood pressure and plasma glycerol; venous plasma concentrations above 0.6 nmolal stimulate lipolysis and cause a 10% increase of resting energy expenditure.
Plasma adrenaline thresholds for most metabolic effects can be reached by modest elevation of resting levels, and it has been demonstrated that such an increase is achieved in many physiological situations. 5 Major problems in measuring sympathoadrenal activity arise from its functional and structural organization. Although it is often referred to as a whole unit, the sympathoadrenal system should be functionally separated into adrenal medulla (AM) and the sympathetic nervous system (SNS); the former is considered the main source of circulating adrenaline, while the latter responds to stimulation with an increase of sympathetic nerve ending discharges of neurotransmitters, ie noradrenaline.
Thus, considering the role of catecholamines on metabolism, a distinction must be made between neural and hormonal effects, the latter mainly exerted by circulating adrenaline. A major methodological issue to be aware of is that each of these two systems can be activated independently from the other by distinct stimuli. It has been shown that cold exposure and postural changes primarily affect sympathetic nervous system activity, while mental effort and caffeine ingestion are considered selective stimuli for the adrenal medulla. During fasting and 2-deoxyglucose-induced hypoglycaemia, adrenomedullary activity is increased, while SNS activity is suppressed. 6 It has been shown that i.c.v. insulin injection selectively activates SNS in rats, ie with sympathetic out¯ow enhanced to the muscles but not to the adrenals. 7 Given these previous considerations, it is not surprising that consistent literature exists dealing with the role of adrenomedullary activity in the pathogenesis of obesity in humans. Numerous studies have compared adrenomedullary function in lean and obese human subjects. The pattern of ®ndings for adrenaline in obesity is discordant from that for noradrenaline suggesting that adrenaline is either normal or low, but not elevated in human obesity. 8 In the Normative Aging Study an inverse correlation between 24 h adrenaline urinary excretion and either BMI or waist-to-hip ratio was found; 9 plasma adrenaline is also negatively correlated with body fat in man. 8 There are many factors, however, confounding the comparison of adrenomedullary activity between lean and obese subjects and particular attention should be devoted to gender and obesity subtype. Several investigations have demonstrated a lower adrenaline response to stimuli like hypoglycaemia, exercise and low calorie diets, 10 in women but not in men. Furthermore, the assessment of adrenomedullary function by venous plasma catecholamine levels does not account for the extraction of adrenaline from peripheral tissues, which may achieve more than 50%. 2 Thus, studies reporting no differences between obese and lean may have been falsely negative due to the abovedescribed methodological limitations. Furthermore, in some studies, the difference between obese and lean subjects was apparent only after exercise.
Little is known about whether reduced adrenaline response should be considered as causative or as a consequence of obesity status. In some investigations post-obese subjects have shown a reduced adrenaline secretion to sham-feeding when compared with controls. 11 In a recent study, however, we provide evidence that before puberty onset the adrenaline response to selective stimulus is similar to that observed in normal lean subjects (Figure 1 ), indicating that adrenomedullary response to stimuli may be an acquired feature of human obesity (Bondi, submitted). What mechanisms underlie the reduced adrenaline secretion in human obesity? It is known that adrenomedullary secretion is affected either by cholinergic or non-cholinergic secretagogues; furthermore a lot of neuropeptides, like NPY, PACAP, VIP etc. may modulate cholinergic transmission. 12 Another physiological modulation of adrenaline secretion is provided by steroid hormones; the strict anatomical relationship and vascular connection between the adrenal medulla and adrenal cortex may provide a morphological basis for the modulation of catecholamine secretion exerted by steroid hormones. Several studies have demonstrated that glucocorticoids inhibit catecholamine secretion. Namely, adrenaline response to hypoglycaemia is reduced after cortisol administration and adrenaline response to glucagon is blunted in Cushing's disease. 13 Sex steroids, particularly oestrogen, affect both catecholamine synthesis and release and we reported a reduced adrenaline response to mental stress in normal male subjects treated with estradiol patches with respect to placebo.
14 Obesity is characterized by enhanced oestrogen production, and an increased responsiveness of hypothalamic ± pituitary ± adrenal axis has been documented in obese subjects. 8 Catecholamines have recently been demonstrated to also play a role in the regulation of total energy balance. Studies in animals provide evidence that catecholamines affect adipose tissue signalling to the brain, in¯uencing leptin synthesis and production. 15 We have shown that adrenaline infusion acutely reduces both leptin mRNA appearance in subcutaneous white adipose tissue and circulating leptin levels in human obese subjects (unpublished data), suggesting that catecholamines may in¯uence food intake In summary, the study of adrenomedullary function in obesity is of great interest, due to the major involvement of adrenaline secretion in the control of energy metabolism and energy balance. Mechanisms underlying adrenomedullary Figure 1 Plasma adrenaline response after caffeine administration in prepubertal lean and obese subjects.
disturbances and its contribution to the pathogenesis, as well as to the maintenance of chronic excess weight in humans, surely deserve further investigation.
